Meyka Pro banner
Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. Fundamental Analysis (TSX: DN.TO)

DN.TOTSX
HealthcareDrug Manufacturers - Specialty & Generic
$0.005
$0.005(50.00%)
Canadian Market opens in 4h 24m

Delta 9 Cannabis Inc. Fundamental Analysis (TSX: DN.TO)

Delta 9 Cannabis Inc. (TSX: DN.TO) shows moderate financial fundamentals with a PE ratio of -0.05, profit margin of -24.65%, and ROE of 48.99%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE48.99%
Cash Position240.67%
PEG Ratio-0.00

Areas of Concern

Operating Margin-30.57%
Current Ratio0.40
We analyze DN.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 140.3/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
140.3/100

We analyze DN.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

DN.TO struggles to generate sufficient returns from assets.

ROA > 10%
-23.64%

Valuation Score

Excellent

DN.TO trades at attractive valuation levels.

PE < 25
-0.05
PEG Ratio < 2
-0.00

Growth Score

Weak

DN.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

DN.TO shows balanced financial health with some risks.

Debt/Equity < 1
-8.87
Current Ratio > 1
0.40

Profitability Score

Moderate

DN.TO maintains healthy but balanced margins.

ROE > 15%
48.99%
Net Margin ≥ 15%
-24.65%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is DN.TO Expensive or Cheap?

P/E Ratio

DN.TO trades at -0.05 times earnings. This suggests potential undervaluation.

-0.05

PEG Ratio

When adjusting for growth, DN.TO's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Delta 9 Cannabis Inc. at -0.12 times its book value. This may indicate undervaluation.

-0.12

EV/EBITDA

Enterprise value stands at 50.24 times EBITDA. This signals the market has high growth expectations.

50.24

How Well Does DN.TO Make Money?

Net Profit Margin

For every $100 in sales, Delta 9 Cannabis Inc. keeps $-24.65 as profit after all expenses.

-24.65%

Operating Margin

Core operations generate -30.57 in profit for every $100 in revenue, before interest and taxes.

-30.57%

ROE

Management delivers $48.99 in profit for every $100 of shareholder equity.

48.99%

ROA

Delta 9 Cannabis Inc. generates $-23.64 in profit for every $100 in assets, demonstrating efficient asset deployment.

-23.64%

Following the Money - Real Cash Generation

Operating Cash Flow

Delta 9 Cannabis Inc. generates limited operating cash flow of $5.44M, signaling weaker underlying cash strength.

$5.44M

Free Cash Flow

Delta 9 Cannabis Inc. produces free cash flow of $4.34M, offering steady but limited capital for shareholder returns and expansion.

$4.34M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

DN.TO converts 1.70% of its market value into free cash.

1.70%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.12

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-8.87

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.40

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

48.99

vs 25 benchmark

ROA

Return on assets percentage

-0.24

vs 25 benchmark

ROCE

Return on capital employed

-0.78

vs 25 benchmark

How DN.TO Stacks Against Its Sector Peers

MetricDN.TO ValueSector AveragePerformance
P/E Ratio-0.0532.14 Better (Cheaper)
ROE4898.73%550.00% Excellent
Net Margin-24.65%30133.00% Weak
Debt/Equity-8.870.56 Strong (Low Leverage)
Current Ratio0.405.70 Weak Liquidity
ROA-23.64%3.00% Weak

DN.TO outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Delta 9 Cannabis Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ